| scholarly article | Q13442814 |
| P50 | author | Dag Aarsland | Q41599688 |
| Kolbjørn Brønnick | Q57741874 | ||
| Sibel Tekin | Q58217374 | ||
| P2093 | author name string | P P De Deyn | |
| M Emre | |||
| J L Cummings | |||
| U Ehrt | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Parkinsonism: onset, progression, and mortality | Q28259134 | ||
| The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease | Q33631292 | ||
| Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging | Q33899794 | ||
| Rivastigmine for dementia associated with Parkinson's disease | Q33983707 | ||
| Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe | Q34114062 | ||
| Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease | Q34341299 | ||
| The heterogeneity of idiopathic Parkinson's disease | Q34621293 | ||
| Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease | Q34733143 | ||
| Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. | Q34874501 | ||
| Dementia associated with Parkinson's disease | Q35172297 | ||
| Range of neuropsychiatric disturbances in patients with Parkinson's disease | Q35453530 | ||
| Health related quality of life in Parkinson's disease: a prospective longitudinal study | Q35572190 | ||
| Psychosis in Parkinson's disease | Q35863404 | ||
| Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? | Q35863410 | ||
| The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
| Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease | Q44063087 | ||
| The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study | Q44171532 | ||
| Behaviour changes in dementia. 2: Are there behavioural syndromes? | Q47617528 | ||
| Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. | Q48540399 | ||
| Behavioural and psychological syndromes in Alzheimer's disease | Q48577678 | ||
| Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease | Q48944777 | ||
| Delusions associated with elevated muscarinic binding in dementia with Lewy bodies | Q49153094 | ||
| Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. | Q50743655 | ||
| Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. | Q51949961 | ||
| Neuropsychological profile of patients with Parkinson's disease without dementia. | Q51950566 | ||
| Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. | Q51974389 | ||
| Mental symptoms in Parkinson's disease are important contributors to caregiver distress. | Q51980927 | ||
| Evidence for impaired encoding and retrieval memory profiles in Parkinson disease. | Q51995445 | ||
| The occurrence of depression in Parkinson's disease. A community-based study. | Q52009711 | ||
| Psychiatric morbidity in patients with Parkinson's disease. | Q52059154 | ||
| Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. | Q53245476 | ||
| A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. | Q53341841 | ||
| Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. | Q55064788 | ||
| Depression in Parkinson's disease | Q72012670 | ||
| Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis | Q73503025 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| patient | Q181600 | ||
| dementia | Q83030 | ||
| P304 | page(s) | 36-42 | |
| P577 | publication date | 2006-07-04 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress | |
| P478 | volume | 78 |
| Q38848346 | A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being |
| Q36885358 | ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia |
| Q52676148 | Abnormal resting-state functional connectivity in posterior cingulate cortex of Parkinson's disease with mild cognitive impairment and dementia. |
| Q38571668 | Advances in the treatment of cognitive impairment in Parkinson's disease |
| Q99637927 | Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review |
| Q38039084 | An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain |
| Q90736949 | Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis |
| Q38391306 | Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials |
| Q38431646 | Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment |
| Q39952638 | Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study. |
| Q37754067 | Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment |
| Q47792370 | Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms |
| Q45852343 | Assessing apathy in everyday clinical practice with the short-form Lille Apathy Rating Scale |
| Q37575663 | Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes |
| Q42765930 | Behavioural and psychological symptoms of dementia associated with Parkinson's disease. |
| Q36616565 | COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease prog |
| Q39457831 | Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature. |
| Q47675318 | Caregiver Experiences Across Three Neurodegenerative Diseases: Alzheimer's, Parkinson's, and Parkinson's With Dementia |
| Q91699939 | Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study |
| Q47146396 | Caregiver distress associated with behavioral and psychological symptoms in mild Alzheimer's disease |
| Q50635221 | Carer burden in apathy and impulse control disorders in Parkinson's disease. |
| Q64082853 | Changes in structural network topology correlate with severity of hallucinatory behavior in Parkinson's disease |
| Q38863643 | Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease |
| Q61932219 | Clinical aspects of Parkinson dementia |
| Q35886708 | Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study |
| Q37987390 | Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study |
| Q43104034 | Co-morbidities of persons dying of Parkinson's disease. |
| Q47923287 | Cognitive and Neuropsychiatric Features in Parkinson's and Lewy Body Dementias |
| Q33917271 | Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy |
| Q48284413 | Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden. |
| Q37968511 | Cognitive impairment in nondemented Parkinson's disease |
| Q89893017 | Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease |
| Q24188194 | Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s Disease |
| Q37104768 | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease |
| Q36374392 | Components of depression in Parkinson disease. |
| Q54946284 | Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study. |
| Q38661735 | Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia |
| Q48171616 | Deep brain stimulation may improve quality of life in people with Parkinson's disease without affecting caregiver burden |
| Q41332581 | Dementia Caregiver Burden: a Research Update and Critical Analysis |
| Q64784966 | Dementia in Parkinson's disease |
| Q92622180 | Dementia in long-term Parkinson's disease patients: a multicentre retrospective study |
| Q36873502 | Depression and apathy in Parkinson's disease |
| Q44130207 | Depression in Parkinson's Disease: The Contribution from Animal Studies |
| Q34572026 | Depression, cognitive impairment and dementia: Why should clinicians care about the web of causation? |
| Q48763785 | Depressive symptoms in Parkinson disease: degree of association and rate of agreement of clinician-based and self-report measures |
| Q47777935 | Differentiating Between Apathy and Depression in Patients With Parkinson Disease Dementia. |
| Q36259025 | Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease. |
| Q90574121 | Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods |
| Q33465315 | Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study |
| Q97538270 | Effect of Biological Treatments on Psychotic Symptoms in Lewy Body Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q41905810 | Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson's Disease Dementia |
| Q50666990 | Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. |
| Q37514014 | Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease? |
| Q45771985 | Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. |
| Q47717568 | Exploring the Phenotype in Mild Cognitive Impairment to Aid the Prediction of Those at Risk of Transitioning to Parkinson Disease and Dementia With Lewy Bodies. |
| Q48335373 | Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. |
| Q48065704 | Factors contributing to caregivers' stress and burden in Parkinson's disease |
| Q47764486 | Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease |
| Q43608778 | Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease |
| Q33567182 | Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease |
| Q39332667 | Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses. |
| Q47704925 | Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients |
| Q36281196 | Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer. |
| Q51038427 | How well do caregivers detect mild cognitive change in Parkinson's disease? |
| Q92315371 | Increased weighting on prior knowledge in Lewy body-associated visual hallucinations |
| Q35757976 | Informal caregivers of clients with neurological conditions: profiles, patterns and risk factors for distress from a home care prevalence study |
| Q39401556 | Investigating emotions in Parkinson's disease: what we know and what we still don't know. |
| Q37892977 | Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"? |
| Q64763013 | L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: A systematic review and meta-analysis of randomized controlled trials |
| Q38024984 | Late-stage Parkinson disease. |
| Q50269272 | Late-stage Parkinson's disease: the Barcelona and Lisbon cohort |
| Q92583952 | Long-Term Efficacy of Memantine in Parkinson' Disease Dementia: An 18-Month Prospective Perfusion Single Photon Emission Computed Tomography Preliminary Study |
| Q35234522 | MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. |
| Q36635473 | Management of Parkinson's disease dementia : practical considerations |
| Q58557484 | Microbial treatment: the potential application for Parkinson's disease |
| Q27007766 | Mild cognitive impairment in Parkinson's disease |
| Q34283576 | Multi-Modal Hallucinations and Cognitive Function in Parkinson’s Disease |
| Q36484606 | Multimodal MRI of the hippocampus in Parkinson's disease with visual hallucinations |
| Q38067143 | Neurobiology of cognitive impairment in Parkinson's disease |
| Q48146819 | Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study. |
| Q89962932 | Neurophysiological Biomarkers of Parkinson's Disease |
| Q36565890 | Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease |
| Q38850369 | Neuropsychiatric symptoms in Alzheimer's disease: Associations with caregiver burden and treatment outcomes |
| Q34983750 | Neuropsychiatric symptoms in Parkinson's disease dementia are associated with increased caregiver burden |
| Q36219665 | Neuropsychiatric symptoms in Parkinson's disease with mild cognitive impairment and dementia |
| Q90918707 | Neuropsychiatric symptoms in Parkinson's disease: association with caregiver distress and disease severity |
| Q38107409 | Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management. |
| Q37714081 | Neuropsychiatric symptoms in untreated Parkinson's disease |
| Q30538175 | Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsy |
| Q48308858 | Neuropsychological functioning in Parkinson's disease: differential relationships with self-reported sleep-wake disturbances |
| Q37853032 | New thoughts on thought disorders in Parkinson's disease: review of current research strategies and challenges |
| Q47587666 | Non-pharmacological interventions for Lewy body dementia: a systematic review |
| Q37950422 | Nonmotor symptoms in Parkinson's disease |
| Q44826435 | Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life |
| Q90219520 | Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease |
| Q42705650 | Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies |
| Q30239814 | Parkinson's Disease and Cognitive Impairment |
| Q51781286 | Parkinson's disease psychosis: presentation, diagnosis and management. |
| Q22252536 | Pharmacological Management of Psychosis in Elderly Patients with Parkinsonism |
| Q58617493 | Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications |
| Q49483673 | Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms |
| Q51872676 | Predictors of caregiver burden in partners of patients with Parkinson's disease. |
| Q34531319 | Predictors of cognitive impairment in an early stage Parkinson's disease cohort |
| Q89552687 | Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson's Disease Cohort (ICICLE-PD) |
| Q59131829 | Psychiatric Manifestation in Patients with Parkinson's Disease |
| Q38206498 | Psychiatric issues in cognitive impairment |
| Q50726621 | Psychiatric symptoms in Parkinson's disease assessed with the SCL-90R self-reported questionnaire. |
| Q48405415 | Psychopathological features in patients with Parkinson's disease and related caregivers' burden. |
| Q39004255 | Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management. |
| Q84777637 | Psychosis in Parkinson's disease |
| Q37103581 | Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. |
| Q39335522 | Psychosis in parkinsonism: an unorthodox approach. |
| Q48311203 | Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms |
| Q35856382 | Randomized controlled expressive writing pilot in individuals with Parkinson's disease and their caregivers. |
| Q33521415 | Reports of neuropsychiatric symptoms of older care recipients by their family members and their foreign home care workers: results from triadic data |
| Q39032421 | Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations |
| Q82552146 | Scales to evaluate psychosis in Parkinson's disease |
| Q41954797 | Separate neural representations of depression, anxiety and apathy in Parkinson's disease. |
| Q37684846 | Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure |
| Q92582895 | The Diagnostic Accuracy of Parkinson's Disease Mild Cognitive Impairment Battery Using the Movement Disorder Society Task Force Criteria |
| Q35098556 | The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up. |
| Q64991670 | The Neuropsychiatric and Motor Profile of GBA-Associated Parkinson's Disease: A Review. |
| Q38751978 | The Parkinson's Active Living (PAL) Program |
| Q44801054 | The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years |
| Q38467172 | The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia |
| Q36311354 | The default mode network is disrupted in Parkinson's disease with visual hallucinations |
| Q48131311 | The emerging biology of delusions. |
| Q45192261 | The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study |
| Q35119259 | The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease |
| Q47105423 | The perception of apathy by caregivers of patients with dementia in Parkinson's disease |
| Q64972290 | The pharmacologic management of depression in Parkinson's disease. |
| Q55177547 | The relationship between stress and Alzheimer's disease. |
| Q37082148 | Treatment of dementia associated with Parkinson's disease |
| Q33767361 | Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease |
| Q43208535 | Use of memantine (akatinol) for the correction of cognitive impairments in Parkinson's disease complicated by dementia |
| Q50749211 | Utility of neuropsychiatric tools in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease: quantitative and qualitative findings. |
| Q64218023 | Validation and optimisation of a touchscreen progressive ratio test of motivation in male rats |
| Q49126634 | Visual hallucinations and cognitive impairment in Parkinson's disease. |
| Q38243013 | Visual hallucinations in Parkinson's disease: theoretical models |
| Q38212033 | What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognition. |
| Q84054821 | [Apathy in Parkinson's disease] |
| Q88019223 | [Nonmotor symptoms in Parkinson's disease] |
| Q86524384 | [Parkinson's disease and psychoses] |
| Q27021220 | Mild cognitive impairment in Parkinson's disease. |
Search more.